Cadila Healthcare Ltd.

Add to My Investments

Healthcare | Drugs & Pharma

we think vacations are for wimps

37 Stocks to buy right now

Join now and be among the first to discover Stock Ideas

Get the Stocks!

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1995

Chairman: Pankaj R Patel

Managing Director: Sharvil P Patel

Group: Cadila

Listing: NSE: CADILAHC, BSE: 532321

Headquarters: Ahmedabad, Gujarat

Website: www.zyduscadila.com

Key Facts

Market cap: R 27,548.91 Cr

Revenue (TTM): R 14,173.60 Cr

Earnings (TTM): R 1,390.00 Cr

Cash: R 879.20 Cr

Total Debt: R 7,899.40 Cr

Promoters' ownership: 74.88%

Liquidity: High

52 Week range: R 206.50 - 352.60

Face value: R1.00

Shares outstanding: 1,02,37,42,600

Stock Performance

Trailing
Annual

Time Period	Cadila Healthcare	S&P BSE Mid Cap	S&P BSE Healthcare
YTD	5.96	4.90	5.04
1 month	2.90	5.93	5.36
3 months	8.71	9.07	9.68
1 Year	-21.22	5.50	0.28
3 Years	-9.02	7.48	-1.51
5 Years	-3.94	7.98	-1.88
10 Years	12.06	8.75	11.24

As on 23-Jan-2020

Year	Cadila Healthcare	S&P BSE Mid Cap	S&P BSE Healthcare
2019	-27.35	-3.05	-3.55
2018	-19.52	-13.31	-5.89
2017	21.55	48.13	0.49
2016	7.20	7.97	-12.88
2015	1.60	7.43	15.06
2014	100.28	54.69	47.43
2013	-9.90	-5.73	22.55

Annual Report (FY18)

Review & Analysis

Who made the right move - FPI or MF?
Yash Rohra . 30-Aug-2019
Contrarian bets
Jugal Harpalani . 16-May-2019
Big shifts
Research Desk . 04-Jul-2018
Best of both worlds
Mohammed Ekramul Haque . 07-Feb-2017
Fall of Pharma
Mohammed Ekramul Haque . 13-Oct-2016

News & Announcements